Showing results (31-40 of 526) with videos related to
Sort By:
Pageof 53
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1985
Mephenytoin metabolism in vitro by human liverM Jurima, T Inaba, W KalowLife Sciences|February 14, 1983
Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugsS V Otton, T Inaba, W KalowClinical Pharmacology and Therapeutics|February 1, 1981
Debrisoquine hydroxylation capacity: problems of assessment in two populationsT Inaba, S V Otton, W KalowClinical Pharmacology and Therapeutics|April 1, 1980
Deficient metabolism of debrisoquine and sparteineT Inaba, S V Otton, W KalowResearch Communications in Chemical Pathology and Pharmacology|March 1, 1978
Seasonal variation of aryl hydrocarbon hydroxylase inducibility in human lymphocytes in cultureA Richter, D Kadar, E Liszka-Hagmajer, et al.European Journal of Clinical Pharmacology|October 10, 1975
Comparative drug elimination in man-diphenylhydantoin and amobarbitalJ F Brien, T Inaba, W KalowClinical Pharmacology and Therapeutics|May 1, 1978
Metabolism of cocaine in manT Inaba, D J Stewart, W KalowLife Sciences|January 2, 1984
Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugsS V Otton, T Inaba, W KalowBritish Journal of Clinical Pharmacology|June 1, 1991
Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase)R F Tyndale, W Kalow, T InabaDrug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1989
Evidence in humans for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P45OIID 1) in vitroR F Tyndale, T Inaba, W KalowPageof 53